Lab Members

Photo of Goldman Lab members

Principal Investigator

Steven A. Goldman, M.D., Ph.D.
Email Steven

Research Interest: Identify the expression patterns of the major categories of stem and progenitor cells of the adult human brain and to use that information to define the signaling pathways that distinguish one progenitor from another, as well as those that distinguish brain tumor stem and progenitor cells from their normal counterparts.

Faculty

Carlos Benitez, Ph.D.
Sr. Associate
Email Carlos

Research Interest:

Development of new analytical methods to better understand in-vivo dynamics of glial replacement

Abdellatif Benraiss, Ph.D.
Research Associate Professor
Email Abdellatif

Research Interest: The use of gene therapeutic strategies to induce and regulate neurogenesis from endogenous neural stem cells in the adult mammalian brain, with a particular emphasis on developing this as a therapeutic strategy in Huntington's disease.

Devin Chandler-Militello, M.S.
Senior Associate
Email Devin

Research Interest: Generation of iPSC and hESC-derived glial progenitor cells for cell therapy.

Gwen Huynh, Ph.D.
Adjunct Assistant Professor
Email Gwen

Research Interest: Transcriptomic and epigenetic regulation of schizophrenia and other psychotic disorders. Application of machine learning techniques to characterize and assess the quality of engineered glial cells.

John Mariani, Ph.D.
Assistant Professor
Email John

Research Interest: Multi-omic bulk and single cell sequencing analyses of human glial chimeric mice to unravel the transcriptional underpinnings of human glial dysfunction in disease.

Steven Schanz
Associate
Email Steven

Research Interest:

Generation of human-glial chimeric mice to model and evaluate cell therapeutic interventions of CNS disease.

Christina Trojel-Hansen, Ph.D.
Adjunct Assistant Professor

Research Interest: Focusing on preclinical and clinical translation of Glia Progenitor Cells

Lisa Zou
Associate
Email Lisa

Research Interest:

Surgical and histological techniques to support in vivo analysis of human glial progenitor cells in chimerized brain models for the goal of translating therapies in glial based neurodegenerative disorders.